ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,053 | +17.0% | 41,403 | +5.0% | 0.00% | – |
| Q2 2023 | $405,299 | +159466.5% | 39,426 | +20.0% | 0.00% | – |
| Q1 2023 | $254 | +31.6% | 32,848 | +25.2% | 0.00% | – |
| Q4 2022 | $193 | -99.9% | 26,233 | +20.7% | 0.00% | – |
| Q3 2022 | $157,000 | -9.8% | 21,737 | +6.5% | 0.00% | – |
| Q2 2022 | $174,000 | – | 20,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |